- News Releases
-
- Aug. 04, 2021 (PDF/115KB)CSR
- Sumitomo Dainippon Pharma Listed Continuously in FTSE4Good Index Series and FTSE Blossom Japan Index of ESG Indices
-
- Aug. 03, 2021Finances
- Posted Conference Call for Q1 FY2021 [Webcast]
-
- Jul. 29, 2021 (PDF/972KB)Finances
- Presentation Material（First Quarter Financial Results for FY2021）
-
- Jul. 29, 2021 (PDF/420KB)Finances
- Supplementary Financial Data (IFRS) for the First Quarter of the Year Ending March 31, 2022
-
- Jul. 29, 2021 (PDF/355KB)Finances
- Summary of Consolidated Financial Results for the First Quarter of the Year Ending March 31, 2022 [IFRS]
Other Notices
-
- Jun. 30, 2021Others
- Posted Factbook 2021
-
- Jun. 24, 2021Corporate (PDF/103KB)
- Sumitomo Dainippon Pharma Announces Release of Movie on Change of Company Name
IR Library
-
Change company name from April 2022
-
Continuing to challenge ourselves to support a healthy future for people
-
Aiming to create innovative pharmaceutical products
-
Targeting sustainable growth
-
Leading our global expansion
-
Thinking BEYOND medication